124 related articles for article (PubMed ID: 8019459)
1. Total lymphoid irradiation, anti-lymphocyte globulin and Campath 1-G for immunosuppression prior to bone marrow transplantation for aplastic anemia after repeated graft rejection.
Or R; Mehta J; Kapelushnik J; Aker M; Naparstek E; Nagler A; Cividalli G; Slavin S
Bone Marrow Transplant; 1994 Jan; 13(1):97-9. PubMed ID: 8019459
[TBL] [Abstract][Full Text] [Related]
2. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
[TBL] [Abstract][Full Text] [Related]
3. Rejection of the second allogeneic graft in a patient with severe aplastic anemia reversed by antilymphocyte globulin and donor lymphocyte infusions.
Ljungman P; Lawler M; Lönnqvist B; Ringdén O; Shanwell A
Bone Marrow Transplant; 1996 Dec; 18(6):1179-81. PubMed ID: 8971392
[TBL] [Abstract][Full Text] [Related]
4. Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
Hamblin M; Marsh JC; Lawler M; McCann SR; Wickham N; Dunlop L; Ball S; Davies EG; Hale G; Waldmann H; Gordon-Smith EC
Bone Marrow Transplant; 1996 May; 17(5):819-24. PubMed ID: 8733704
[TBL] [Abstract][Full Text] [Related]
5. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Hale G; Waldmann H
Bone Marrow Transplant; 1994 May; 13(5):597-611. PubMed ID: 8054913
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation for severe aplastic anaemia: cost/benefit of increased immunosuppression.
Gordon-Smith EC
Bone Marrow Transplant; 1991; 7 Suppl 2():103-5. PubMed ID: 1908725
[No Abstract] [Full Text] [Related]
7. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J
Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
[TBL] [Abstract][Full Text] [Related]
8. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
[TBL] [Abstract][Full Text] [Related]
9. [Unrelated match bone marrow transplantation for severe aplastic anemia].
Urase F; Ishikawa H; Kanbara M; Hazu S; Tsuji K; Ashida T; Tsubaki K; Horiuchi A
Rinsho Ketsueki; 1993 Dec; 34(12):1584-6. PubMed ID: 8295334
[TBL] [Abstract][Full Text] [Related]
10. In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation.
Willemze R; Richel DJ; Falkenburg JH; Hale G; Waldmann H; Zwaan FE; Fibbe WE
Bone Marrow Transplant; 1992 Apr; 9(4):255-61. PubMed ID: 1600413
[TBL] [Abstract][Full Text] [Related]
11. Total lymphoid irradiation and total body irradiation for allogeneic bone marrow transplantation in aplastic anemia.
Kurisu K; Hishikawa Y; Taniguchi M; Kamikonya N; Miura T; Kanamaru A; Kakishita E; Kai S; Hara H
Radiat Med; 1991; 9(4):148-52. PubMed ID: 1961940
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation for severe aplastic anemia following preparation with cyclophosphamide and total lymphoid irradiation.
Ramsay NK; Kim TH; McGlave P; Goldman A; Nesbit ME; Krivit W; Woods WG; Kersey JH
Prog Clin Biol Res; 1984; 148():315-24. PubMed ID: 6379669
[No Abstract] [Full Text] [Related]
13. Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
Naparstek E; Delukina M; Or R; Nagler A; Kapelushnik J; Varadi G; Strauss N; Cividalli G; Aker M; Brautbar C; Waldmann H; Hale G; Slavin S
Exp Hematol; 1999 Jul; 27(7):1210-8. PubMed ID: 10390197
[TBL] [Abstract][Full Text] [Related]
14. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.
Hale G; Jacobs P; Wood L; Fibbe WE; Barge R; Novitzky N; Toit C; Abrahams L; Thomas V; Bunjes D; Duncker C; Wiesneth M; Selleslag D; Hidajat M; Starobinski M; Bird P; Waldmann H
Bone Marrow Transplant; 2000 Jul; 26(1):69-76. PubMed ID: 10918407
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of CAMPATH-1H in BMT patients.
Rebello P; Cwynarski K; Varughese M; Eades A; Apperley JF; Hale G
Cytotherapy; 2001; 3(4):261-7. PubMed ID: 12171714
[TBL] [Abstract][Full Text] [Related]
16. Late graft failure 8 years after first bone marrow transplantation for severe acquired aplastic anemia.
Dufour C; Dallorso S; Casarino L; Corcione A; Pistoia V; Bacigalupo A; Morreale G; Dini G
Bone Marrow Transplant; 1999 Apr; 23(7):743-5. PubMed ID: 10218856
[TBL] [Abstract][Full Text] [Related]
17. Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody.
Champlin R; Ho W; Bayever E; Winston DJ; Lenarsky C; Feig SA; Gale RP
Prog Clin Biol Res; 1984; 148():227-38. PubMed ID: 6379661
[No Abstract] [Full Text] [Related]
18. Severe migratory polyarthritis following in vivo CAMPATH-1G.
Varadi G; Or R; Rund D; Orbach H; Slavin S; Nagler A
Bone Marrow Transplant; 1995 Dec; 16(6):843-5. PubMed ID: 8750280
[TBL] [Abstract][Full Text] [Related]
19. [Hematopoietic stem-cell transplantation in aplastic anemia].
Hernández-Rivera EG
Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
[TBL] [Abstract][Full Text] [Related]
20. Use of cyclophosphamide and total lymphoid irradiation combined with cyclosporine in bone marrow transplantation for transfused severe aplastic anemia.
Miyamura K; Kojima S; Takeyama K; Matsushita T; Fukuda M; Horibe K; Minami S; Morishima Y; Matsuyama K; Kodera Y
Bone Marrow Transplant; 1988 Sep; 3(5):457-61. PubMed ID: 3056553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
